Prostate Cancer Trends in Developing Countries
Keywords:
Prostate cancer, European Countries, prostate specific antigen (PSA), subsequent biopsyAbstract
Prostate cancer is the commonest cancer in USA and most European Countries and
is the 2nd commonest cancer among males globally. An estimated 1.1 million men worldwide
were diagnosed with prostate cancer in 2012, accounting for 15% of the cancers diagnosed
in men. Incidence of this disease varies more than 25-fold worldwide; the rates are highest in
Australia/New Zealand and Northern America (ASR 111.6 and 97.2 per 100,000 respectively),
and in Western and Northern Europe, because the practice of prostate specific antigen (PSA)
testing and subsequent biopsy has become widespread in those regions.
